Eulerpool Terminal
The edge that pays for itself.
Current Processa Pharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
25.50 USD
+1,102.83 %
Median
25.50 USD
+1,102.83 %
Max
26.25 USD
Min
25.25 USD
Last Price
2.12 USD
Buy
6
Hold
2
Sell
0
The average target price for Processa Pharmaceuticals is 25.50 USD. (+1,102.83 % above the current price)
The median price target of Processa Pharmaceuticals is 25.50 USD.
Stock analysts from many renowned investment banks are closely examining the Processa Pharmaceuticals stock. They conclude their professional Processa Pharmaceuticals stock analyses with a clear recommendation for the Processa Pharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 6 | 1 | 0 | — |
| 2026-02-01 | 6 | 2 | 0 | 25.50 USD |
| 2026-02-01 | 6 | 2 | 0 | 25.50 USD |
| 2026-01-01 | 6 | 2 | 0 | 25.50 USD |
| 2025-12-01 | 6 | 2 | 0 | 25.50 USD |
| 2025-12-01 | 6 | 2 | 0 | 1.02 USD |
Processa Pharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Processa Pharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 14.00 M USD | -1.00 M USD | -8.17 USD |
| 2026e | 10.00 M USD | — | — |
| 2027e | 10.00 M USD | — | — |